Qualigen Therapeutics Inc Total Liabilities

Latest as of September 2025: $4.92 Million USD

Qualigen Therapeutics Inc total liabilities. Based on the latest financial reports, Qualigen Therapeutics Inc (QLGN) has total liabilities worth $4.92 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Qualigen Therapeutics Inc asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Qualigen Therapeutics Inc (2012–2024)

Total liabilities of Qualigen Therapeutics Inc from 2012 to 2024. This chart illustrates how Qualigen Therapeutics Inc's total liabilities have evolved over time, based on quarterly financial data.

Qualigen Therapeutics Inc Competitors by Total Liabilities

The table below lists competitors of Qualigen Therapeutics Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Plant Advanced Technologies SA PA:ALPAT	France	€6.53 Million
Agro Phos India Limited NSE:AGROPHOS	India	Rs833.07 Million
Helios Energy Ltd AU:HE8	Australia	AU$1.91 Million
MRG Metals Ltd AU:MRQ	Australia	AU$182.35K
Auddia Inc NASDAQ:AUUD	USA	$853.85K
Cardio Diagnostics Holdings Inc NASDAQ:CDIO	USA	$499.78K
Hybrid Financial Services Limited NSE:HYBRIDFIN	India	Rs108.44 Million
HLT Global Bhd KLSE:0188	Malaysia	RM76.94 Million

Liability Composition Analysis (2012–2024)

This chart breaks down Qualigen Therapeutics Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Qualigen Therapeutics Inc total assets.

Liquidity & Leverage Metrics

Qualigen Therapeutics Inc Total Liabilities Ratios Explained

Qualigen Therapeutics Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	8.83	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.13	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.11	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Qualigen Therapeutics Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Qualigen Therapeutics Inc (2012–2024)

The table below shows the annual total liabilities of Qualigen Therapeutics Inc from 2012 to 2024.

Year	Total Liabilities	Change
2024-12-31	$2.01 Million	-51.47%
2023-12-31	$4.14 Million	-59.90%
2022-12-31	$10.32 Million	+64.52%
2021-12-31	$6.27 Million	-42.11%
2020-12-31	$10.83 Million	+538.30%
2019-12-31	$1.70 Million	-71.40%
2018-12-31	$5.93 Million	+119.14%
2017-12-31	$2.71 Million	-13.60%
2016-12-31	$3.13 Million	+131.33%
2015-12-31	$1.35 Million	+7.97%
2014-12-31	$1.25 Million	+39.73%
2013-12-31	$897.96K	-1.38%
2012-12-31	$910.48K	--

About Qualigen Therapeutics Inc

NASDAQ:QLGN USA Biotechnology

Market Cap

$4.74 Million

Market Cap Rank

#28626 Global

#5884 in USA

Share Price

$2.33

Change (1 day)

+0.30%

52-Week Range

$2.27 - $3.21

All Time High

$446250.00